These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam. Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT Clin Pharmacol Ther; 2006 Apr; 79(4):362-70. PubMed ID: 16580904 [TBL] [Abstract][Full Text] [Related]
25. Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections. Pascual A; Csajka C; Buclin T; Bolay S; Bille J; Calandra T; Marchetti O Clin Infect Dis; 2012 Aug; 55(3):381-90. PubMed ID: 22610925 [TBL] [Abstract][Full Text] [Related]
26. Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study. Myrianthefs P; Markantonis SL; Evaggelopoulou P; Despotelis S; Evodia E; Panidis D; Baltopoulos G Int J Antimicrob Agents; 2010 May; 35(5):468-72. PubMed ID: 20188523 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients. Peng LW; Lien YH Am J Kidney Dis; 2005 Jan; 45(1):162-6. PubMed ID: 15696456 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of oral voriconazole in patients with cystic fibrosis. Clifton IJ; Whitaker P; Metcalfe R; Phillip M; Shaw N; Conway SP; Peckham DG J Antimicrob Chemother; 2011 Oct; 66(10):2438-40. PubMed ID: 21791443 [No Abstract] [Full Text] [Related]
29. Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency. Gerin M; Mahlaoui N; Elie C; Lanternier F; Bougnoux ME; Blanche S; Lortholary O; Jullien V Ther Drug Monit; 2011 Aug; 33(4):464-6. PubMed ID: 21743382 [TBL] [Abstract][Full Text] [Related]
30. Clearance of intravitreal voriconazole. Shen YC; Wang MY; Wang CY; Tsai TC; Tsai HY; Lee YF; Wei LC Invest Ophthalmol Vis Sci; 2007 May; 48(5):2238-41. PubMed ID: 17460285 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration. Fuhrmann V; Schenk P; Jaeger W; Miksits M; Kneidinger N; Warszawska J; Holzinger U; Kitzberger R; Thalhammer F J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725 [TBL] [Abstract][Full Text] [Related]
32. Voriconazole concentrations and outcome of invasive fungal infections. Miyakis S; van Hal SJ; Ray J; Marriott D Clin Microbiol Infect; 2010 Jul; 16(7):927-33. PubMed ID: 19845698 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of terbinafine after oral administration of a single dose to Hispaniolan Amazon parrots (Amazona ventralis). Evans EE; Emery LC; Cox SK; Souza MJ Am J Vet Res; 2013 Jun; 74(6):835-8. PubMed ID: 23718650 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of Amitriptyline HCl and Its Metabolites in Healthy African Grey Parrots ( Psittacus erithacus ) and Cockatoos (Cacatua Species). Visser M; Ragsdale MM; Boothe DM J Avian Med Surg; 2015 Dec; 29(4):275-81. PubMed ID: 26771316 [TBL] [Abstract][Full Text] [Related]
35. Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient. Robatel C; Rusca M; Padoin C; Marchetti O; Liaudet L; Buclin T J Antimicrob Chemother; 2004 Jul; 54(1):269-70. PubMed ID: 15175271 [TBL] [Abstract][Full Text] [Related]
36. Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study. Soler-Palacín P; Frick MA; Martín-Nalda A; Lanaspa M; Pou L; Roselló E; de Heredia CD; Figueras C J Antimicrob Chemother; 2012 Mar; 67(3):700-6. PubMed ID: 22190607 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Walsh TJ; Karlsson MO; Driscoll T; Arguedas AG; Adamson P; Saez-Llorens X; Vora AJ; Arrieta AC; Blumer J; Lutsar I; Milligan P; Wood N Antimicrob Agents Chemother; 2004 Jun; 48(6):2166-72. PubMed ID: 15155217 [TBL] [Abstract][Full Text] [Related]
38. Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety. Purkins L; Wood N; Greenhalgh K; Allen MJ; Oliver SD Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):10-6. PubMed ID: 14616408 [TBL] [Abstract][Full Text] [Related]
39. Steady-state pharmacokinetics and metabolism of voriconazole in patients. Geist MJ; Egerer G; Burhenne J; Riedel KD; Weiss J; Mikus G J Antimicrob Chemother; 2013 Nov; 68(11):2592-9. PubMed ID: 23766489 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model. González GM; Portillo OJ; Uscanga GI; Andrade SE; Robledo M; Rodríguez C; Elizondo M J Antimicrob Chemother; 2009 Sep; 64(3):571-3. PubMed ID: 19570754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]